Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for Variation: WBVar00145348

expand all nodes | collapse all nodes | view schema

Name Class

WBVar00145348EvidencePaper_evidenceWBPaper00032966
NamePublic_nameft15
Other_nameCE39527:p.Glu116Lys
W10G6.2a.1:c.346G>A
W10G6.2b.1:c.376G>A
CE39528:p.Glu126Lys
W10G6.2a.2:c.346G>A
HGVSgCHROMOSOME_X:g.16258923C>T
Sequence_detailsSMapS_parentSequenceW10G6
Flanking_sequencesgatgagaataatgttgatctcggaccaagtagaggaaaacgtatgttttggccataaggat
Mapping_targetW10G6
Type_of_mutationSubstitutiongaPaper_evidenceWBPaper00032966
SeqStatusSequenced
Variation_typeAllele
OriginSpeciesCaenorhabditis elegans
StrainWBStrain00023654
WBStrain00023656
LaboratoryKQ
StatusLive
AffectsGeneWBGene00004789
TranscriptW10G6.2b.1 (12)
W10G6.2a.1 (12)
W10G6.2a.2 (12)
InteractorWBInteraction000537334
WBInteraction000537335
WBInteraction000537360
WBInteraction000537361
WBInteraction000537362
WBInteraction000537371
GeneticsInterpolated_map_positionX23.7003
DescriptionPhenotypeWBPhenotype:0001171Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
RemarkTable S1Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
WBPhenotype:0001236Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
Remark"On the contrary, Phsp-6::gfp, expression was enhanced in the sgk-1(ft15) gain of function mutants (Figure 3), which live shorter (Figure 1B), upon prohibitin depletion."Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
EQ_annotationsGO_termGO:0034514PATO:0000460Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
Phenotype_assayGenotypePhsp-6::gfp; phb-1(RNAi)Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
Phenotype_not_observedWBPhenotype:0000120Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
Remark"Although we did not observe any significant effect on mitochondrial function using the ATP and mitochondrial membrane potential assays, interestingly, Western Blot analysis revealed that sgk-1(ok538) and rict-1(ft7) mutants have reduced protein levels of PHB-1 (Figure 8). In contrast, daf-2(e1370) and daf-2(e1370); sgk-1(ok538) loss of function mutants did not show any alteration in the PHB-1 protein levels (Figure 8). Likewise, the gain of function of sgk-1(ft15) animals did not show an alteration in the protein content of PHB-1 (Figure 8)."Paper_evidenceWBPaper00045812
Curator_confirmedWBPerson2987
WBPhenotype:0000231Paper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Remarksgk-1 (ft15) mutants displayed wild-type body sizePaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Semi_dominantPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Variation_effectHypermorph_gain_of_functionPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
EQ_annotationsLife_stageWBls:0000041PATO:0000460Paper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
WBPhenotype:0001182Paper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Remarksgk-1 (ft15) mutants displayed wild-type fat contentPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Semi_dominantPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Variation_effectHypermorph_gain_of_functionPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
Phenotype_assayTreatmentNile Red stainingPaper_evidenceWBPaper00032966
Curator_confirmedWBPerson2021
ReferenceWBPaper00032966
WBPaper00045812
MethodSubstitution_allele